PM
PA MedTech VC fund
Pfaffikon, SwitzerlandFounded 2021
PA MedTech VC fund focuses on investing in MedTech startups developing next-generation medical devices, primarily within the cardiovascular and ophthalmology sectors, and more broadly across Life Sciences and HealthTech. The firm primarily invests in Series B rounds in United States-based startups, often within the Shifamed portfolio, aiming for rapid exits and de-risked opportunities.
100% of their portfolio is in Healthcare. Their most common stage is series-b (50% of deals). Average disclosed round size is $34.6M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$1B
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Laza Medical, Inc. | Series A | $36M | Dec 2023 |
 Akura Medical | Series B | $35M | Oct 2023 |
 Tioga Cardiovascular | Series C | $30M | Feb 2023 |
 Adona Medical | Series B | $37.5M | Apr 2022 |
Top Co-Investors
The General Partnership4 shared
Cormorant Asset Management3 shared
AMD Ventures3 shared
Shifamed angel investors3 shared
Lilly Asia Ventures1 shared
Excelestar Ventures1 shared
Last updated: 10 April 2026